secwatch.observer — SEC 8-K summary
======================================

Issuer:     Citius Pharmaceuticals, Inc. (CTXR)
CIK:        0001506251
Form:       8-K
Filed at:   2024-09-11T23:59:59+00:00
Accession:  0001213900-24-077777
Event type: regulatory
Sentiment:  negative
Materiality: 0.80
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Citius Pharma receives Nasdaq delisting determination for bid price non-compliance; plans hearing
--------------------------------------------------------------------------------

- Received delisting determination on Sept 10, 2024 after failing to regain $1.00 bid price compliance by extended deadline of Sept 9, 2024.
- Company will request hearing before Nasdaq Hearing Panel, which automatically stays suspension/delisting pending outcome.
- Panel may grant additional extension of up to 180 days from delisting letter date to regain compliance.
- No assurance that relief or continued listing will be granted. Stock trades on Nasdaq Capital Market under CTXR.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024077777/0001213900-24-077777-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1506251/000121390024077777/ea0214282-8k_citius.htm
  HTML page:      https://secwatch.observer/filing/0001213900-24-077777

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer